Crystal deal tombstone recognizing the acquisition of Munich, Germany-based Humediq. The company’s technology aids radiation therapy by providing patient management information.
(8ALJ480)
These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.
Crystal deal tombstone recognizing the acquisition of Munich, Germany-based Humediq. The company’s technology aids radiation therapy by providing patient management information.
(8ALJ480)Custom crystal tombstone celebrating a second close of Series A financing for Fusion Pharmaceuticals. The Hamilton, Ontario-based firm is focused on radiotherapeutics for treating cancer.
(8ALJ479)Custom crystal tombstone marking a private placement by Swiss biopharmaceutical company Auris Medical. Ladenburg Thalmann acted as exclusive placement agent.
(8AMF064)Pyramid-shaped deal toy commemorating convertible notes issued by Ligand Pharmaceuticals, based in San Diego. Goldman Sachs and Barclays acted as Joint Book-Running Managers for the issue.
(8ALJ247)Custom crystal commemorating a research collaboration involving Neurocrine Biosciences and Jnana Therapeutics. The research centers on finding new small-molecule therapeutics targeting central nervous system disorders.
(8ALJ498)Star-shaped crystal deal toy recognizing the sale by TPG Growth of NorthStar Anesthesia, based in Irving, Texas.
(8ALJ313)Custom deal toy, incorporating a map of Costa Rica, commemorating the initial public offering (IPO) by Establishment Labs. Med-tech firm is the first Costa Rican company to go public on the American Stock Exchange.
(8AJH238)Custom crystal deal toy commemorating a follow-on offering by EnteroMedics. Ladenburg Thalmann acted as sole bookrunning manager for the follow-on issue by the medical device developer. Based in St. Paul, Minnesota, the company was renamed ReShape Lifesciences in October 2017.
(7AMF287)Deal toys in the healthcare and pharmaceutical space reflect a broad range of financial transactions. These deals involve an array of industry players, including drug companies, hospital chains, medtech firms, manufacturers of medical devices, developers of diagnostic equipment, senior living facilities, pharmacies, and testing laboratories, as well as healthcare-focused funds and venture capital firms.
The transactions themselves include mergers and acquisitions, initial public offerings, bond issues, financings, private placements, and early-stage funding rounds.
But also represented here are transactions more unique to the sector, such as drug licensing, royalty, and commercialization agreements.
The custom designs in these galleries also celebrate non-financial industry achievements and milestones. You will see here, for instance, commemoratives involving submissions and approvals from the Food & Drug Administration (FDA) and European Medicines Agency (EMA), therapeutic studies, joint ventures, successful preclinical and in-human testing stages, and product launches.
These milestones can be commemorated with designs incorporating items unique to the specific event, achievement, or innovation being recognized. These design options include, for example, Lucite embedments of actual drug vials and medical devices.
You’ll also find here commemoratives for a variety of other sector-related events. These include custom awards and gifts honoring speakers and attendees at national and international health summits and medical conferences.
"*" indicates required fields
